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ABSTRACT 
Objective: Abdominal aortic aneurysms (AAAs) are associated with oxidative stress and the 
inflammatory response. We investigated the hypothesis that the known antioxidant ascorbic 
acid, which can also promote elastin and collagen production by smooth muscle cells, would 
prevent AAA formation in a rat model. 
Methods: An intraluminal elastase and extraluminal calcium chloride-induced rat AAA model 
was used, and the animals were divided into 3 groups: control (Group C, N = 18), the aorta 
wrapped with saline impregnated gelatin hydrogel sheet (Group G, N = 18), and the aorta 
wrapped with gelatin hydrogel sheet incorporating ascorbic acid (Group A, N = 18). Wrapping 
of the sheet was completed at the end of treatment for AAA creation. Aortic dilatation ratio was 
measured and aortic tissues were further examined for oxidative stress and oxidative DNA 
damage using biochemical and histological techniques.   
Results: Aortic dilatation at both 4 and 8 weeks was inhibited in Group A (dilatation ratio (%) 
at 4 weeks: 186.2 ± 21.8 in Group C, 152.3 ± 10.2 in Group G, 126.8 ± 11.6 in Group A, P 
< .0001; dilatation ratio (%) at 8 weeks: 219.3 ± 37.5 in Group C, 194.0 ± 11.6 in Group G, 
145.7 ± 8.3 in Group A, P = .0002). Elastin and collagen content were significantly preserved in 
Group A (elastin: P = .0015; collagen: P < .0001). The messenger RNA (mRNA) expressions of 
matrix metalloproteinase (MMP)-9, monocyte chemotactic protein-1, interleukin-1β and tissue 
necrosis factor-α (P = .0024, P < .0001, P < .0001, P < .0001, respectively) was down-regulated 
in Group A (P = .0024), while tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 
were both up-regulated in Group A (TIMP-1: P = .0014; TIMP-2: P < .0001). Gelatin 
zymography showed activities of pro MMP-2, MMP-2 and MMP-9 were significantly 
suppressed in group C (p< .0001 for each). Reactive oxygen species (ROS) expression and 
8-hydroxydeoxyguanosine (8-OHdG) and cluster of differentiation (CD) 68 staining were 
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significantly suppressed in Group A (ROS expression: P < .0001; 8-OHdG positive cells: P 
< .0001; CD68 positive cells: P < .0001)  
Conclusions: Controlled release of ascorbic acid using gelatin hydrogel sheet attenuated AAA 
formation through antioxidant and anti-inflammatory effect, regulation of MMP-2, TIMP-1 and 
TIMP-2, and preserving elastin and collagen in this animal model.   
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Clinical relevance 
 Current options for treating AAAs are limited to open or endovascular repair. A 
simple method other than replacement would be highly beneficial to patients. Wrapping the 
dilated aorta has been reported to be effective in preventing future dilatation and rupture. 
Gelatin hydrogel is not only suitable for wrapping vessels, but also is biocompatible and does 
not cause inflammatory changes. Furthermore, it can deliver drugs directly to the target organ 
over period of time with superior effect than systemic application. Application of ascorbic acid 
impregnated gelatin hydrogel sheet may enable to attenuate the future dilatation of AAAs in 
human.    
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INTRODUCTION 
 The pathogenesis of abdominal aortic aneurysms (AAA) has been examined in the 
past decades. Inflammation and tissue degeneration have been proven to play key roles in this 
process.1 Moreover, the enhanced oxidative stress that occurs during the inflammatory response 
has been demonstrated to contribute to the formation of AAAs. 2, 3  
 Ascorbic acid has powerful antioxidant properties and can protect tissue from 
oxidative damages.4 This compound provides a vascular defense against oxidative stress by 
scavenging free radicals and by increasing endothelial nitric oxide synthase activity.5 In 
addition, ascorbic acid has been reported to enhance elastin and collagen production from aortic 
smooth muscle cells, and these two proteins have been demonstrated to be crucial components 
of the vascular structure in previous in vitro studies. 6, 7, 8  
 Gelatin hydrogel sheet has been demonstrated to provide stable release of several 
substances9, 10, 11 and to have excellent vessel fitting characteristic, with the effect of 
circumferential mechanical support, improving structural and physiological properties.12 This 
material and methodology can prolong the effect of the medication in a target tissue selectively 
and continuously. Furthermore, it has a great potential to provide superior therapeutic efficacy 
for topical pharmacological applications on aneurysmal vessels compared with systemic 
application.13  
 In the current study, we hypothesized that wrapping gelatin hydrogel sheet to provide 
the sustained release of ascorbic acid could attenuate aneurysmal development by both 
protecting against oxidative stress and by promoting elastin and collagen production.  
 
METHODS 
In vivo controlled release of ascorbic acid from gelatin hydrogel sheet 
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 The gelatin used in the present study was isolated using an alkaline process from 
bovine bone with an isoelectric point of 4.9 and molecular mass of 99 000 kDa (Nitta Gelatin 
Co, Osaka, Japan). The gelatin sheets were prepared by chemical cross-linking of a 5% bovine 
bone gelatin solution with glutaraldehyde. Gelatin sheets of 20 mm2/0.3 mm were prepared and 
immersed in 50 mmol/L glycine aqueous solution at 37 °C for 1 hour to block the residual 
aldehyde groups of glutaraldehyde. The sheets were then freeze-dried and sterilized by ethylene 
oxide gas. Ascorbic acid was incorporated into the gelatin hydrogel sheets by immersion in a 
200 mg/ml ascorbic acid solution for 30 minutes. The release test was performed in a 1mL 
phosphate buffered saline solution containing 0.01 weight% TWEEN® 80 (Sigma-Aldrich, 
Tokyo, Japan) by soaking a 5 mm by 5 mm ascorbic acid-impregnated gelatin hydrogel sheet to 
assess the concentration of ascorbic acid at 12, 24, 48, 72, 96 and every 48 subsequent hours, 
up to 336 hours. The sheet was removed at each endpoint, and the solution was combined with 
1 mL of 10% metaphosphoric acid and centrifuged. The supernatant was used for the assay 
using a Vitamin C Assay Kit (Cosmo Bio Co, LTD, Tokyo, Japan), following the instructions 
for the use. An oxidizing agent was added to each sample, which was incubated for 5 minutes 
at room temperature. Next, 5% metaphosphoric acid/2% stannum chloride was added to the 
sample. After the addition of 2, 4- dinitrophenylhydrazine to the sample and 3 hours of 
incubation at 37 °C, 85% sulfate was added. Lastly, the samples were transferred to 96–well 
plate, and their absorbances were measured at 530 nm. To determine the amount of ascorbic 
acid in each sample, the absorbance value of each sample was compared with a set of standard 
ascorbic acid samples that were prepared in parallel. 
In vivo controlled release of ascorbic acid from gelatin hydrogel sheet 
A 5 mm by 10 mm ascorbic acid-impregnated gelatin hydrogel sheet was implanted 
subcutaneously in 4 separate parts of the body, left and right side of the back and chest and 
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abdomen, in 3 rats to assess the concentration of ascorbic acid in tissue. At 10, 24, 108 and 216 
hours, the sheet was removed and the subcutaneous tissue was taken and was weighed. Then 
the sample was homogenized with 5.4% metaphosphoric acid and centrifuged. The supernatant 
was used for the assay using a Vitamin C Assay Kit (Cosmo Bio Co, LTD, Tokyo, Japan). 
Animal Model 
 In the present study, 8-week-old male Sprague-Dawley rats (SLC Inc., Shizuoka, 
Japan) (N = 54) were used and handled according to the Guidelines for Animal Experiments at 
Kobe University Graduate School of Medicine (permission number P080120) and the Guide for 
the Care and Use of Laboratory Animals (http://www.nap.edu/catalog/5140.html).  
The experimental AAA saccular model was described previously.14 Briefly, a 1-cm 
segment of the infrarenal abdominal aorta was exposed via a midline laparotomy. Subsequently, 
the aorta was filled with 30 μl (30 U) of porcine pancreatic elastase (135 U/mg; Elastin 
Products Company, Owensville, USA) and 0.5 M CaCl2 (Sigma-Aldrich, Tokyo, Japan) soaked 
gauze was wrapped around the region simultaneously for 20 minutes. The abdominal incision 
was closed in layers, and rats were allowed to recover. 
Ascorbic acid impregnate hydrogel sheet administration 
 Ascorbic acid was incorporated into the gelatin hydrogel sheets by immersion in a 
200 mg/ml ascorbic acid solution for 30 minutes prior to implantation. Following elastase 
infusion and calcium chloride exposure of the abdominal aorta, the rats were further treated 
according to each group. For Group C, (control group), the abdomen was closed in layers 
without any additional procedure. For Group G, the treated aorta was wrapped 
circumferentially with a 5 mm by 10 mm plain gelatin hydrogel sheet that was submerged in 
natural saline for 30 minutes. For Group A, the treated aorta was enveloped with a 5 mm by 10 
mm ascorbic acid incorporated gelatin hydrogel sheet. 
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 The 1-week samples (N = 6 in each group) were used for the molecular analyses, 
immuohistochemical analyses and in situ imaging. The 4-week samples (N = 6 in each group) 
were used for the morphometric, histologic and quantitative analyses. The 8-week samples (N 
= 6 in each group) were used for the morphometric analyses. 
Macroscopic assessments 
 The animals were anesthetized, and the abdominal aorta was exposed and 
photographed using a digital camera (Leica IC D, Leica Microsystems, Wetzlar, Germany). The 
maximal dimension of the transverse minor axis of the abdominal aorta and the aortic diameter 
at the infrarenal proximal neck site were measured under physiologic conditions using an 
optical micrometer prior to isolation. The dilation ratio was calculated according to the 
following formula: dilation ratio (%) = [maximal aneurysm diameter / native aortic diameter] X 
100. AAA was defined as when the dilation ratio exceeded 150%. 
Specimen preparation 
 The treated 1-cm aortic segments in each group were isolated at each study endpoint. 
The 1-week aortic segment was cut into two equal portions transversely. One segment was used 
for messenger RNA (mRNA) analysis, and the remaining portion was further bisected for the 
immunohistochemical analysis. The first portion was fixed in 10% formalin, dehydrated in a 
graded ethanol bath, cleaned in xylene, and paraffin-embedded. The remainder was embedded 
in Tissue-Tek O.C.T. Compound (Sakura Finetek Japan Co, Tokyo, Japan) in liquid nitrogen 
and stored at -80 °C until required. The 4-week aortic segments were bisected for histological 
assessment and quantification of elastin and collagen. The 4-week aortic segments for the 
histological analysis were fixed in 10% formalin, dehydrated in a graded ethanol bath, cleaned 
in xylene, and paraffin-embedded. 
Histology 
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 Paraffin-embedded 5 μm-thick sections were stained by hematoxylin and eosin 
(H&E) for general appearance, with elastic Van Gieson (EVG) for elastin, and with picrosirius 
red (PSR) for collagen. The images for the sections were captured with a microscopic system 
Biozero (KEYENCE Co, Osaka, Japan) and were assessed using BZ-H1M (KEYENCE) and 
Image J 1.41 software (National Institute of Health, Bethesda, MD). The areas of collagen in a 
cross-sectional aortic wall were semiquantified using Image J plug-in Color Counter with a 
color threshold mask. The collagen content was calculated by dividing the collagen-positive 
area by the cross-sectional aortic wall area in the PSR-stained sections. The method that was 
used for this analysis was described by Perrée et al.15 The collagen content was expressed as a 
percentage of the total area. 
Quantification of elastin 
 The rat aortic elastin content was quantified using the Fastin elastin assay kit 
(Biocolor; www.biocolor.co.uk), following the manufacturer’s instructions. Briefly, the rat aorta 
samples were homogenized in 0.25 M oxalic acid. After centrifuging, the supernatants were 
treated with an elastin-precipitating reagent and centrifuged. After discarding the supernatants, 
the elastin pellet was treated with a dye reagent that binds to elastin. Lastly, the bound 
dye-elastin complex was resuspended, and the dye was disassociated from the elastin. The 
absorbance of each sample was measured at 513 nm and compared with a set of standard 
elastin samples. The elastin content of each rat aorta sample was expressed as a percentage of 
the dry weight of the vessel.  
Immunohistochemistry 
 The immunohistochemical staining was performed on paraffin-embedded sections of 
1-week samples of the aorta using monoclonal antibody that is specific for 
8-hydroxydeoxyguanosine (8-OHdG) (Japan Institute for the Control of Aging, Shizuoka, 
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Japan), which marks oxidative DNA damage,16 for cluster of differentiation (CD) 68 for 
macrophages and for monocyte chemotactic protein (MCP)-1 (Santa Cruz Biotechnology, Inc., 
Dallas, TX, US). Briefly, deparaffinized sections were incubated overnight at 4 °C with a 
primary antibody against 8-OHdG (5.0 μg/ml), CD68 (1.0 μg/ml) and MCP-1 (4.0 μg/ml). 
Following three washes, the sections were incubated at room temperature for 30 minutes in a 
solution with an anti-mouse IgG secondary antibody (K4001; Dako). The microscopic digital 
images of five random fields on each section were scanned in a frame that was composed of 
500 μm by 380 μm rectangles, and the number of 8-OHdG-positive cells and CD68-positive 
cells in aortic wall was counted using Dynamic cell count BZ-H1C software (KEYENCE). 
In situ superoxide Imaging 
 The 1-week samples of aortic wall embedded in Tissue-Tek® O.C.T. Compound were 
cut into 10 μm sections. Dihydroethidium (DHE) (Invitrogen, Tokyo, Japan) was used to 
evaluate tissue superoxide levels in situ, as previously described.17 The sections were incubated 
with DHE in phosphate-buffered saline in a dark, humidified chamber for 30 minutes at 37°C. 
DHE fluorescence was detected through a 580 nm filter, and DHE fluorescence images of five 
randomly selected fields on each section were scanned with Biozero software in a frame that 
was composed of 500 μm by 380 μm rectangles. DHE fluorescence of the aortic sections was 
quantified using Dynamic cell count BZ-H1C software. The mean fluorescence was 
semiquantified and expressed relative to the values that were obtained for native rat tissue. 
Quantitative real-time polymerase chain reaction analysis 
 Total RNA was isolated from graft samples using an RNeasy fibrous tissue mini-kit 
(Qiagen, Valencia, CA, USA), following the manufacturer’s instructions. The RNA was 
transcribed and amplified to complimentary DNA (cDNA) using a high-capacity cDNA 
reverse-transcription kit (Applied Biosystems, Foster City, CA, USA). Quantitative real-time 
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polymerase chain reaction (PCR) analyses for mRNA levels of matrix metalloproteinase 
(MMP)-2, MMP-9, tissue inhibitors of metalloproteinase (TIMP)-1, TIMP-2, interleukin 
(IL)-1β and tumor necrosis factor (TNF)-α were performed using an ABI Prism 7500 sequence 
detection system (Applied Biosystems) with TaqMan universal PCR master mix (Applied 
Biosystems) and TaqMan real-time PCR primers (Applied Biosystems). The expression levels 
of each mRNAs were divided by the mRNA level of the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  
Gelatin zymography  
Proteins from aortic specimens were extracted using a buffer containing 50mM 
Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.2% sodium dodecyl sulfate, and 1mM 
ethylenediaminetetraacetic acid, supplemented with protease inhibitors (20 μg/mL aprotinin,10 
μg/mL leupeptin, and 1mM phenylmethylsulfonyl fluoride). To determine gelatinolytic 
activities of MMP-2 and MMP-9 in the treated aorta, gelatin-zymography kit (Primary Cell Co, 
Hokkaido, Japan) was used according to the manufacturer’s instructions. The protein 
concentration was standardized with a microbicinchoninic acid protein assay kit (Pierce, 
Rockford, Ill), and then protein (20 μg) was applied in each lane for the electrophoresis. 
Densitometric analysis of the lytic bands was performed by Image J software. 
Statistical analysis.  
 The database management and statistical analysis were performed using JMP 
software (SAS Institute Inc., Cary, NC, USA). All of the values are expressed as the means ± 
standard deviation of the mean of the obtained values for each rat in a given group. The 
comparisons between multiple groups were performed using one-way analysis of variance, 
followed by the Tukey-Kramer honestly significant difference test. A value of P < .05 was 
considered to be statistically significant. 
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RESULTS 
Release test 
 In vitro release test demonstrated that ascorbic acid was rapidly released from gelatin 
hydrogel sheet during the first 48 hours and was gradually released over a period of several 
weeks (Fig. 1A). The concentration of ascorbic acid reached 30 μg/ml and the sheet did not 
dissolve in phosphate-buffered saline at the completion of the 14-day release test. On the 
contrast, in vivo release test showed the ascorbic acid concentration of tissue was maintained 
around 100μg/ml for days (Fig. 1B). The actual sheet wrapped around the abdominal aorta in 
rat retroperitoneum was clearly present at 1 week, and was barely detected at 4 weeks, then 
completely dissolved at 8 weeks.  
Macroscopic assessments 
 Aneurysm formation was observed at 4 and 8 weeks. The macroscopic findings are 
given in Figure 2. According to the AAA definition in the present study, AAAs formed in 100% 
of the rats in Group C at both 4 and 8 weeks. Among rats in Group G, 83.3% exhibited AAA 
formation at 4 weeks, and 100% exhibited AAAs at 8 weeks. None of the rats in Group A had 
developed AAAs at 4 weeks, and only 16.7% formed AAAs at 8 weeks. Significant differences 
were observed in the AAA formation rates at 4 and 8 weeks in Group A compared with Groups 
C (at 4 weeks, P = .0005; at 8 weeks, P < .0001) and G (at 4 weeks, P = .0034; at 8 weeks, P 
= .0118). The dilation ratios of the AAAs at 4 and 8 weeks were also significantly lower in 
Group A (126.8 ± 11.6% at 4 weeks, 145.7 ± 8.3% at 8 weeks) than those that were observed in 
Groups C (186 ± 21.8% at 4 weeks, P < .001; 219.3 ± 37.5% at 8 weeks, P < .0001) and G 
(152.3 ± 10.2% at 4 weeks, P = .0034; 194.0 ± 11.6% at 8 weeks, P = .0025). 
Elastin and collagen 
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 EVG staining revealed various degrees of degeneration and disruption of the elastic 
lamellae in all the Groups C, G and A (Fig. 3). But the elastin content in Group A was 
significantly preserved compared with Groups C and G (elastin (μg/tissue weight mg): 31.0 ± 
1.6 in Group C, 37.3 ± 6.9 in Group G, 47.4 ± 11.8 in Group A, Fig. 4A). 
 PSR staining demonstrated preserved wall thickness, with high collagen contents, in 
Group A compared with the other two groups (Fig. 3). The semi-quantification of collagen 
content revealed that Group A contained significantly higher collagen levels compared with 
Groups C and G (collagen positive area (%): 4.7 ± 0.4 in Group C, 3.9 ± 0.4 in Group G, 9.2 ± 
0.4 in Group A, Fig. 4B).  
Antioxidant Effect of ascorbic acid 
 The DHE staining revealed that relative ROS expression in the aortic wall was 
significantly suppressed in Group A, especially in the outer layer of the aorta (Fig. 5A), 
compared with Groups C and G (4.6 ± 0.7 in Group C, 4.2 ± 0.4 in Group G, 1.8 ± 0.2 in Group 
A, Fig. 5B). Similarly, the number of 8-OHdG-positive cells in the aortic walls was 
significantly decreased in Group A compared with Groups C and G (131.3 ± 16.1 cells in 
Group C, 121.8 ± 16.1 cells in Group G, 75.3 ± 24.2 cells in Group A, Fig. 5A and 5C).  
Inflammatory response 
 Inflammation is believed to contribute to the etiology of MMP-regulated and 
TIMP-regulated AAA formation. The mRNA expression levels of MMP-2 were similar in all 3 
of the groups (Fig. 6A). However, the mRNA expressions of MMP-9 were significantly 
down-regulated in Group A compared with both Groups C and G (2.36 ± 0.30 in group C, 2.30 
± 1.52 in group G, 0.40 ± 0.17 in group A). In contrast, the mRNA expression levels of TIMP-1 
and TIMP-2 were significantly up-regulated in Group A compared with both Group C and 
Group G. The mRNA expression levels of TIMP-1 and TIMP-2 in Groups A, C, and G were 
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0.52 ± 0.15 and 0.41 ± 0.09, 0.83 ± 0.38 for TIMP-1, respectively (Fig. 6A). These values were 
0.35 ± 0.07, 0.52 ± 0.06, and 2.97 ± 0.77 for TIMP-2, respectively. In addition, the mRNA 
expression levels of inflammatory cytokines, MCP-1, IL-1β and TNF-α, were all down 
regulated in group A (MCP-1: 0.31 ± 0.07 in group C, 0.26 ± 0.05 in group G, 0.13 ± 0.02 in 
group A, IL-1β: 1.93 ± 0.18 in group C, 0.42 ± 0.25 in group G, 0.17 ± 0.18 group A, TNF-α: 
2.43 ± 0.17 in group C, 0.76 ± 0.20 in group G, 0.20 ± 0.10 in group A, Fig. 7A). Similarly in 
CD 68 staining, the number of positive cells in the aortic walls was significantly decreased in 
group A (87.8 ± 28.1 cells in group C, 46.8 ± 9.5 cells in group G, 17.2 ± 6.4 cells in group A, 
Fig.7B and 7C). The distribution of MCP-1 were also reduced in group A. Moreover, MMP 
activity was evaluated by gelatin zymography (Fig.6B) and group A were significantly 
down-regulated in all the pro MMP-2, MMP-2 and MMP-9 activities (Fig.6C). 
 
DISCUSSION 
 The current study demonstrated that wrapping an ascorbic acid-saturated gelatin 
hydrogel sheet around the aorta prevented AAA formation in a rat model. This effect was 
mediated by an increased level of antioxidant in cooperation with the reinforcement of the 
aortic wall via preservation of its elastin and collagen.  
 In vitro release tests demonstrated that an ascorbic acid-containing hydrogel sheet 
could only generate a concentration of approximately 30 μg/ml, but in vivo release test showed 
the concentration could reach around 100μg/ml. The biodegradation of the material in vitro is 
expected to deliver a higher concentration as Konishi et al 13 showed in their experiment of the 
gelatin hydrogel. They demonstrated that the drug contained in gelatin hydrogel sheet only 
released 10 to 30% in the in vitro test, but with the degradation of gelatin hydrogel in vivo, the 
drug was released more and had effect superior to topical application. The initial release of 
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ascorbic acid from the sheet that was observed in the release test is assumed to be due to the 
compound on the surface of the sheet which was not bound to the gelatin hydrogel. Previous 
report in human showed that the plasma vitamin C concentration can only reach 220 μmol/L, 
approximately 38μg/ml, with doses of 3 g for 6 times daily.18 Thus direct delivery of ascorbic 
acid by gelatin hydrogel can be expected to reach much higher level of concentration than that 
can be reached with oral supplementing.  
 Elastin and collagen are important load-bearing components of the aortic wall, and 
the destruction of these elements leads to aortic dilatation.19 We conclusively demonstrated that 
aortic walls that received a topical application of ascorbic acid via a gelatin hydrogel sheet 
contained larger contents of elastin and collagen and exhibited preserved morphology in the rat 
AAA model; furthermore, AAA formation was attenuated by this treatment. The elastin and 
collagen were better preserved by the antioxidant and anti-inflammatory effects of ascorbic 
acid and may have been newly produced from aortic smooth muscle cells. There are several 
reports that support this latter hypothesis. Tajima et al8 previously reported that the production 
of tropoelastin was induced by the presence of ascorbic acid when aorta-derived smooth muscle 
cells were cultured. Moreover, Qiao et al6 reported that the addition of ascorbic acid to the cell 
culture resulted in procollagen maturation. Ascorbic acid is required in the proline 
hydroxylation of both collagen and elastin,20 and hydroxyproline is crucial for collagen and 
elastin stability, which gives strength to the cellular matrix.  
 Oxidative stress has been demonstrated to play a significant role in human AAA 
formation and progression.2 Our group recently reported that the formation and the 
development of AAAs were inhibited by the suppression of ROS production.21 Ascorbic acid is 
a well-known antioxidant that cannot be produced in the human body. We performed 
preliminary experiment in our AAA model (N=2) with oral ascorbic acid supplementation of 
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200 mg daily for 2 weeks, but it could not prevent dilatation of the AAA (dilatation at 4 weeks: 
170% and 223%). This result is consistent with Jiang et al 22 previously described in their study 
that oral supplementation of antioxidant vitamins had minimal effects on prevention of an 
Angiotensin II-induced AAA formation. However, with our method of delivering ascorbic acid 
to the target aorta, the DHE staining of aortic cross-section in the present study revealed that 
ROS expression was apparently suppressed in the outer layer of the aortic wall. Moreover, 
fewer 8-OHdG positive cells were observed in the aortas exposed to ascorbic acid compared 
with the other groups. Both findings indicate that gelatin hydrogel sheet successfully released 
ascorbic acid and had antioxidant effect.  
 Both smooth muscle cells and infiltrating inflammatory cells produce MMPs. 
Specifically, MMP-2 and MMP-9 are crucial in the formation and the development of AAAs.23 
As we described previously, elastase and calcium chloride-treated control aortas exhibited 
markedly increased MMP-2 and MMP-9 activity in whole aorta homogenates.14 The 
down-regulations of TIMP-1 and TIMP-2 are reported to result in proteolytic extracellular 
matrix degradation, a process that also plays key role in aneurysm formation.24 In the present 
study, MCP-1 and CD 68staining of AAA wall and mRNA expressions of MCP-1, IL-1β, 
TNF-α showed ascorbic acid sheet successfully suppressed recruitment of inflammatory cells 
and inflammatory responses, and subsequently pro MMP-2, MMP-2 and MMP-9 activities 
were inhibited by treatment with ascorbic acid-impregnated hydrogel sheet; an up-regulation of 
TIMP-1 and TIMP-2 was also observed in the ascorbic acid treated group.  
 We performed additional experiment to evaluate the treatment effect of the ascorbate 
sheet on existing AAA. The animals at 1 week following AAA induction were treated with 
plain hydrogel sheet (N=2) and ascorbic acid impregnated hydrogel sheet (N=2). The plain 
sheet could not attenuate the AAA progression (dilatation rate at 1 week 117% and 236%; 
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dilatation rate at 4 weeks: 234% and 220%) but ascorbic acid sheet did prevent from further 
dilatation (dilatation reate at 1 weeek: 113% and 133%; dilatation rate at 4 weeks: 134% and 
154%). This result shows that ascorbic acid impregnated sheet has possible treatment effect on 
existing AAA. 
 
Limitations 
 The limitation of the present study is that the elastase and calcium chloride-induced 
rat AAA is not completely similar to human AAA as it lacks several prominent features of the 
human lesions, such as atherosclerosis and intraluminal thrombosis. However, we demonstrated 
that our AAA model is simple, easy to perform, highly reliable and reproducibly creates a 
saccular aneurysm.14 
  
Conclusions 
 We demonstrate that the wrapping of ascorbic acid-impregnated gelatin hydrogel 
sheet has significant protective effects against AAA formation in an elastase and calcium 
chloride induced rat AAA model with suppressed of inflammatory response and oxidative 
stress.. Ascorbic acid treatment has possible positive effect on elastin and collagen preservation 
and production. This treatment also had a protective effect against oxidative stress.  
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Figure legends 
Fig 1. A: The in vitro controlled release test of ascorbic acid over-time.  
 B: The in vivo controlled release test of ascorbic acid over-time 
Fig 2.  A: The photographs show treated lesions of abdominal aorta at 4 weeks in each group. 
Group C, control; Group G, saline-impregnated gelatin hydrogel; Group A, ascorbic 
acid-impregnated gelatin hydrogel. 
 B: Dilatation ratio (%) at 4-week and 8-week. 
Fig 3. Histologic findings of abdominal aorta cross-sections at 4 weeks after staining with 
hematoxylin eosin (H&E) and elastic van Gieson (EVG) for the morphologic 
assessment, and with picrosirius red (PSR) for the collagen content assessment. The 
upper rows are at the original magnification (40X; Bar, 300μm), and the lower panels 
are at the original magnification (400X; Bar, 100μm). Native, normal rats; Group C, 
control; Group G, saline-impregnated gelatin hydrogel; Group A, ascorbic 
acid-impregnated gelatin hydrogel. 
Fig 4.  The quantification of elastin (A) and collagen (B) at 4 weeks. All of the data are 
expressed as the mean ± standard deviation for 6 rats in each group. NS, Not 
significant. Native, normal rats; Group C, control; Group G, saline-impregnated 
gelatin hydrogel; Group A, ascorbic acid-impregnated gelatin hydrogel. 
Fig 5.  The assessment of oxidative stress in the aortic wall at day 7.  
 A, Abdominal aorta cross-sections at 1 week after staining with dihydroethidium 
(DHE) for the in situ imaging of superoxide levels and 8-hydroxydeoxyguanosine 
(8-OHdG) staining for the assessment of oxidative DNA damage. Star, inner aortic 
lumen. Native, normal rats; Group C, control; Group G, saline-impregnated gelatin 
hydrogel; Group A, ascorbic acid-impregnated gelatin hydrogel.  
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 B, The dihydroethidium (DHE) count was semiquantified and expressed relative to 
values that were obtained for native rat. All of the data are expressed as the mean ± 
standard deviation for 6 rats (average of randomly selected five fields) in each group.  
 C, 8-OHdG positive cell count in a 500 μm by 380 μm rectangle of the aortic wall.  
 All of the data are expressed as the mean ± standard deviation for 6 rats (average of 
randomly selected five fields) in each group. 
Fig 6. A: Messenger RNA (mRNA) expression of matrix metalloprotenases, given as a ratio 
of glyceraldehyde-3-phosphatedehydrogenase GAPDH expression in the abdominal 
aorta at 1 week. All of the data are expressed as the mean ± standard deviation for 6 
rats in each group. MMP: matrix metalloproteinase, TIMP: tissue inhibitors of 
metalloproteinase. NS, Not significant. Native, normal rats; Group C, control; Group 
G, saline-impregnated gelatin hydrogel; Group A, ascorbic acid-impregnated gelatin 
hydrogel. * P< .05, **P< .01, ***P< .001 
B: Gelatin zymography documents gelatinolytic activities of pro MMP-2, MMP-2 and 
MMP-9 
C: Densitometric analysis of the MMP activities. 
Fig. 7 A: Messenger RNA (mRNA) expressions of inflammatory cytokines, given as a ratio 
of glyceraldehyde-3-phosphatedehydrogenase GAPDH expression in the abdominal 
aorta at 1 week. All of the data are expressed as the mean ± standard deviation for 6 
rats in each group. MCP-1, monocyte chemotactic protein-1; IL-1β, Interleukin-1β; 
tissue necrosis factor-α, TNF-α. NS, not significant * P< .05, **P< .01, ***P< .001 
 B: Cluster differentiation (CD) 68 positive cell count in a 500 μm by 380 μm rectangle 
of the aortic wall. All of the data are expressed as the mean ± standard deviation for 6 
rats (average of randomly selected five fields) in each group. 
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 C: CD68 and monocyte chemotactic protein (MCP)-1 staining for assessment of 
macrophage recruitment 
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